GlassScriptPhysician profile
Tracy L Collins
NPI 1194863639
$772.29
in general payments reported to CMS, 2019-2025
11 companies · $118 in 2025
The $118 reported for 2025 was less than what a typical Psychiatry provider received nationally (typical 2025 total: $176).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $265 · 2020: $109 · 2021: $30.45 · 2022: $68.34 · 2023: $71.82 · 2024: $110 · 2025: $118.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $300.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $299.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astrazeneca Pharmaceuticals LP | $226.55 | 2020-2025 | Breztri |
| Novo Nordisk INC | $110.20 | 2024 | |
| Sunovion Pharmaceuticals INC. | $99.51 | 2019-2022 | |
| Janssen Pharmaceuticals, INC | $84.36 | 2019-2023 | Invega Sustenna, Invega Trinza |
| Neurocrine Biosciences, INC. | $79.72 | 2019-2023 | Ingrezza |
| Lundbeck LLC | $49.64 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $40.88 | 2019 | |
| Teva Pharmaceuticals USA, INC. | $27.30 | 2023 | Austedo |
| Allergan, INC. | $25.57 | 2019 | |
| Abbvie INC. | $14.55 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.01 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tracy Collins listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.